Skip to main content
. 2020 Apr 27;12(4):149–158. doi: 10.4240/wjgs.v12.i4.149

Figure 3.

Figure 3

Survival of patients stratified by mammalian target of rapamycin inhibitor monotherapy vs combination therapy with calcineurin inhibitor (P = 0.59). mTOR: Mammalian target of rapamycin.